PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
